Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis
Report and Segment Forecast, 2025| Grand View Research, Inc
“The global hemodialysis vascular grafts market size was valued at USD 209.1
million in 2018. It is likely to expand at a CAGR of 4.1 % over the forecast period.”
The global Hemodialysis Vascular Grafts Market size is expected to reach USD 276.5 million by 2025, according
to a new report by Grand View Research, Inc., progressing at a CAGR of 4.1% during the forecast period.
Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological
access products due to technological advancements in the field are some of the factors contributing to revenue
growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are
promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for
vascular grafts over the forecast period.
The global hemodialysis vascular graft market, by raw material, was dominated by PTFE grafts with a revenue
share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High
product penetration, wide availability, and comparatively cheaper products are supplementing the dominance
of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its
adoption, owing to lower possibility of rejection and infection of these products.
North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue.
The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of
Follow Us:
the market in the country can be attributed to growing number of renal impaired patients undergoing
hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.
Developing economies such as China and India have lower availability of kidney donors as compared to
developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of
hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to
exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing
awareness regarding safety of AVG, and rising healthcare expenditure.
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market
Further Key Findings From the Report Suggest:

North America dominated the market in 2017, owing to geightened awareness regarding treatment
options available, increasing adoption of hemodialysis access grafts, and technological advancements in
AVG

Asia Pacific is anticipated to be the fastest growing regional hemodialysis vascular graft market with a
CAGR of 6.6 % between 2018 and 2025

Some of the key market players in this market are W.L. Gore & Associates; C. R. Bard, Inc.; Terumo
Medical Corporation; LeMaitre Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.;
CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc.
Grand View Research has segmented the global hemodialysis vascular graft market on the basis of raw material
types, and region:
Hemodialysis Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2014 - 2025)

Polyester

Polytetrafluoroethylene

Polyurethane

Biological Materials
Follow Us:
Hemodialysis Vascular Grafts Regional Outlook (Revenue, USD Million, 2014 - 2025)





North America
o
U.S.
o
Canada
Europe
o
U.K.
o
Germany
Asia Pacific
o
Japan
o
China
Latin America
o
Brazil
o
Mexico
Middle East & Africa
o
Follow Us:
South Africa
Table of Content of Hemodialysis Vascular Grafts Market
Chapter 1 Executive Summary
1.1 Market Snapshot, 2017 (USD Million)
Chapter 2 Research Methodology
2.1 Information procurement
Chapter 3 Market Variables, Trends& Scope
3.1 Market Segmentation& Scope
3.1.1 Market driver analysis
3.1.1.1 Increase in prevalence of renal disorders
3.1.1.2 Presence of well-defined regulatory guidelines in developed economies
3.1.1.3 Increasing adoption of biological access grafts
3.1.2 Market restraint analysis
3.1.2.1 Low reimbursement rate and high out-of-pocket expenditure in emerging markets
3.1.2.2 Economic pricing for peritoneal dialysis procedures
3.1.2.3 Low diagnosis rate of patients with kidney diseases
3.1.2.4 Increase in number of patients undergoing peritoneal dialysis in developed economies
3.2 Global hemodialysis vascular grafts market - PESTEL Analysis
3.3 Industry Analysis - Porter’s
3.4 Global Hemodialysis Vascular Grafts Market Regulatory Scenario
3.5 Average Selling Price by Product, USD (2014 to 2025)
Chapter 4 Global Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis
4.1 Global hemodialysis vascular grafts market: Raw material movement analysis
4.2 Polyester
4.2.1 Hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Polytetrafluoroethylene
4.3.1 Market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
4.4 Polyurethane
4.4.1 Hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
4.5 Biological materials
4.5.1 Market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
Follow Us:
4.5.2 Human Saphenous and Umbilical Veins
4.5.3 Human saphenous and umbilical veins biological material hemodialysis vascular grafts market,
revenue estimates and forecasts, 2014 - 2025 (USD Million)
4.5.4 Tissue Engineered Materials
4.5.5 Tissue engineered biological material hemodialysis vascular grafts market, revenue estimates and
forecasts, 2014 - 2025 (USD Million)
Chapter 5 Hemodialysis Vascular Graft Market: Regional Estimates & Trend Analysis, by Raw Materials
5.1 Global Hemodialysis Vascular Market Share by Region, 2014 & 2025
5.2 North America
5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.2.3 U.S.
5.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.2.4 Canada
5.2.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.4.1 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.3 Europe
5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.3.3 U.K.
5.3.3.1 Market, market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.3.2 Market, market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.3.4 Germany
5.3.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.4.1 Market estimates and forecasts, 2014 - 2025, by raw material, (USD Million)
5.4 Asia Pacific
5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.4.3 Japan
5.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
Follow Us:
5.4.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.4.4 China
5.4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.5 Latin America
5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.2 Market estimates and forecasts, by raw material,2014 - 2025 (USD Million)
5.5.3 Brazil
5.5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.5.4 Mexico
5.5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.6 MEA
5.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.6.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
5.6.3 South Africa
5.6.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
5.6.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Company Profiles
6.2.1 W. L. Gore & Associates.
6.2.1.1 Company Overview
6.2.1.2 Financial Performance
6.2.1.3 Product Benchmarking
6.2.1.4 Strategic Initiatives
6.2.2 C. R. Bard, Inc.
6.2.2.1 Company Overview
6.2.2.2 Financial Performance
6.2.2.3 Product Benchmarking
Follow Us:
6.2.2.4 Strategic Initiatives
6.2.3 Terumo Medical Corporation.
6.2.3.1 Company Overview
6.2.3.2 Financial Performance
6.2.3.3 Product Benchmarking
6.2.3.4 Strategic Initiatives
6.2.4 Lemaitre Vascular, Inc.
6.2.4.1 Company Overview
6.2.4.2 Financial Performance
6.2.4.3 Product Benchmarking
6.2.4.4 Strategic Initiatives
6.2.5 Getinge AB.
6.2.5.1 Company Overview
6.2.5.2 Financial Performance
6.2.5.3 Product Benchmarking
6.2.6 VASCULAR GENESIS.
6.2.6.1 Company Overview
6.2.6.2 Financial Performance
6.2.6.3 Product Benchmarking
6.2.7 InnAVasc Medical, Inc.
6.2.7.1 Company Overview
6.2.7.2 Financial Performance
6.2.7.3 Product Benchmarking
6.2.7.4 Strategic Initiatives
6.2.8 CryoLife, Inc.
6.2.8.1 Company Overview
6.2.8.2 Financial Performance
6.2.8.3 Product Benchmarking
6.2.8.4 Strategic Initiatives
6.2.9 MERIT MEDICAL SYSTEMS, INC
6.2.9.1 Company Overview
Follow Us:
6.2.9.2 Financial Performance
6.2.9.3 Product Benchmarking
6.2.9.4 Strategic Initiatives
6.2.10 Proteon Therapeutics Inc.
6.2.10.1 Company Overview
6.2.10.2 Financial Performance
6.2.10.3 Product Benchmarking
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global hemodialysis vascular grafts market size is expected to reach USD 276.5 million by 2025